{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:07:20Z","timestamp":1790701640666,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K03072"],"award-info":[{"award-number":["JP25K03072"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K10094"],"award-info":[{"award-number":["JP25K10094"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpet.2026.105013","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:00:03Z","timestamp":1786978803000},"page":"105013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prior Toll-like receptor 3 stimulation abolishes the ability of a MAPK\/ERK kinase inhibitor to increase lipopolysaccharide-induced nitric oxide production concomitant with tumor necrosis factor-\u03b1 suppression"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0983-6704","authenticated-orcid":false,"given":"Ryota","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaojia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaily","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruto","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichi","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2026.105013_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.105013_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102172","article-title":"Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics","volume":"70","author":"Kaur","year":"2022","journal-title":"Curr Opin Chem Biol"},{"issue":"3","key":"10.1016\/j.jpet.2026.105013_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.it.2015.01.003","article-title":"Nitric oxide synthase in innate and adaptive immunity: an update","volume":"36","author":"Bogdan","year":"2015","journal-title":"Trends Immunol"},{"issue":"9","key":"10.1016\/j.jpet.2026.105013_bib4","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1016\/S0021-9258(18)42704-4","article-title":"Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s13054-023-04690-5","article-title":"The role of endotoxin in septic shock","volume":"27","author":"Kellum","year":"2023","journal-title":"Crit. Care"},{"key":"10.1016\/j.jpet.2026.105013_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172940","article-title":"JAK-STAT-dependent regulation of scavenger receptors in LPS-activated murine macrophages","volume":"871","author":"Hashimoto","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpet.2026.105013_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2017.10.005","article-title":"LPS enhances expression of CD204 through the MAPK\/ERK pathway in murine bone marrow macrophages","volume":"266","author":"Hashimoto","year":"2017","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jpet.2026.105013_bib9","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1128\/IAI.67.8.3824-3829.1999","article-title":"Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1\/MEK1-MEK2\/ERK1-ERK2 pathway","volume":"67","author":"van der Bruggen","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s42003-021-02149-3","article-title":"Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line","volume":"4","author":"Pudewell","year":"2021","journal-title":"Commun Biol"},{"issue":"9","key":"10.1016\/j.jpet.2026.105013_bib11","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.3390\/ijms23095158","article-title":"Discovery of Raf family is a milestone in deciphering the Ras-mediated intracellular signaling pathway","volume":"23","author":"Zhao","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.jpet.2026.105013_bib12","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","article-title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","volume":"37","author":"Dankner","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jpet.2026.105013_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100223","article-title":"Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review","volume":"6","author":"Solares","year":"2021","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.jpet.2026.105013_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/CCO.0000000000000709","article-title":"Triplet combination of BRAF, MEK and PD-1\/PD-L1 blockade in melanoma: the more the better?","volume":"33","author":"Trojaniello","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41420-023-01674-w","article-title":"MEK inhibitors increase the mortality rate in mice with LPS-induced inflammation through IL-12-NO signaling","volume":"9","author":"Hashimoto","year":"2023","journal-title":"Cell Death Discov"},{"issue":"5","key":"10.1016\/j.jpet.2026.105013_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/cc5055","article-title":"Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis","volume":"10","author":"Cavaillon","year":"2006","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clim.2008.08.015","article-title":"Gene-specific control of the TLR-induced inflammatory response","volume":"130","author":"Foster","year":"2009","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.jpet.2026.105013_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","article-title":"Endotoxin tolerance: new mechanisms, molecules and clinical significance","volume":"30","author":"Biswas","year":"2009","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.jpet.2026.105013_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0040-2016","article-title":"Toll-like receptor signaling and its inducible proteins","volume":"4","author":"Satoh","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.jpet.2026.105013_bib20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.chom.2017.07.008","article-title":"Interferon-\u03b3-driven iNOS: a molecular pathway to terminal shock in arenavirus hemorrhagic fever","volume":"22","author":"Remy","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.jpet.2026.105013_bib21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1189\/jlb.68.6.897","article-title":"Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction","volume":"68","author":"Xing","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jpet.2026.105013_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106152","article-title":"Trametinib alleviates lipopolysaccharide-induced acute lung injury by inhibiting the MEK-ERK-Egr-1 pathway","volume":"80","author":"Chen","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.jpet.2026.105013_bib23","first-page":"6351","article-title":"MEK inhibitor trametinib attenuates neuroinflammation and cognitive deficits following traumatic brain injury in mice","volume":"12","author":"Huang","year":"2020","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.jpet.2026.105013_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1006\/bbrc.2000.2184","article-title":"Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo","volume":"268","author":"Jaffee","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.jpet.2026.105013_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"van Loo","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.jpet.2026.105013_bib27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0092-8674(00)00210-5","article-title":"TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2\/ERK-dependent pathway","volume":"103","author":"Dumitru","year":"2000","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jpet.2026.105013_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2015.01.160","article-title":"Trametinib, a novel MEK kinase inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor (TNF)-\u03b1 production and endotoxin shock","volume":"458","author":"Shi-Lin","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/09680519060120010201","article-title":"GM-CSF priming of human monocytes is dependent on ERK1\/2 activation","volume":"12","author":"Lendemans","year":"2006","journal-title":"J. Endotoxin Res"},{"issue":"6","key":"10.1016\/j.jpet.2026.105013_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.jpet.2026.105013_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1568010054526359","article-title":"Nitric oxide production and signaling in inflammation","volume":"4","author":"Korhonen","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"4","key":"10.1016\/j.jpet.2026.105013_bib32","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1074\/jbc.M114.599985","article-title":"Extracellular signal-regulated kinase mediates expression of arginase II but not inducible nitric-oxide synthase in lipopolysaccharide-stimulated macrophages","volume":"290","author":"Jin","year":"2015","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.jpet.2026.105013_bib33","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.4049\/jimmunol.163.12.6403","volume":"163","author":"Feng","year":"1999","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jpet.2026.105013_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097276","article-title":"L-ascorbate attenuates the endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation and NF-\u03baB translocation in cortical neurons\/glia cocultures","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib35","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bbrc.2017.11.143","article-title":"Tyrosine kinase Fyn regulates iNOS expression in LPS-stimulated astrocytes via modulation of ERK phosphorylation","volume":"495","author":"Ko","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.jpet.2026.105013_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5001\/omj.2011.21","article-title":"Food-drug interactions","volume":"26","author":"Bushra","year":"2011","journal-title":"Oman Med J"},{"key":"10.1016\/j.jpet.2026.105013_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100414","article-title":"Classification of drugs for evaluating drug interaction in drug development and clinical management","volume":"41","author":"Maeda","year":"2021","journal-title":"Drug Metab Pharmacokinet"},{"issue":"13","key":"10.1016\/j.jpet.2026.105013_bib38","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1073\/pnas.1918095117","article-title":"Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy","volume":"117","author":"Bhatt","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpet.2026.105013_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41522-017-0034-1","article-title":"Human microbiome signatures of differential colorectal cancer drug metabolism","volume":"3","author":"Guthrie","year":"2017","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"10.1016\/j.jpet.2026.105013_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat Commun"},{"issue":"20","key":"10.1016\/j.jpet.2026.105013_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.105013_bib42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis\u2014current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clinic Rev Allerg Immunol"},{"issue":"8","key":"10.1016\/j.jpet.2026.105013_bib43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","article-title":"Strategies for targeting cytokines in inflammatory bowel disease","volume":"24","author":"Neurath","year":"2024","journal-title":"Nat Rev Immunol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:44:30Z","timestamp":1790700270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022356526012139"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105013","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prior Toll-like receptor 3 stimulation abolishes the ability of a MAPK\/ERK kinase inhibitor to increase lipopolysaccharide-induced nitric oxide production concomitant with tumor necrosis factor-\u03b1 suppression","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"105013"}}